Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
---|
11/01/2012 | CA2832663A1 Risperidone sustained release microsphere composition |
11/01/2012 | CA2829171A1 Pyrazolidin-3-one derivatives |
11/01/2012 | CA2829170A1 Ethynyl derivatives as positive allosteric modulators of the mglur5 |
10/31/2012 | EP2518064A1 Novel aryl urea derivative |
10/31/2012 | EP2518059A1 4-amino-1,3-thiazine or oxazine derivative |
10/31/2012 | EP2518054A1 Amide compound |
10/31/2012 | EP2518052A1 Substituted 4-aminocyclohexane derivatives |
10/31/2012 | EP2517711A1 Hyperlipemia-ameliorating agent, anemia-ameliorating composition, uric-acid-level-reducing composition, and foods and beverages |
10/31/2012 | EP2517710A1 Tamper-resistant oral opioid agonist formulations |
10/31/2012 | EP2517704A1 Pharmaceutical composition for treating parkinson's disease and preparation method thereof |
10/31/2012 | EP2517701A1 Curing and prophylactic agent applied during the use of alcohol and psychoactive substances |
10/31/2012 | EP2517700A1 Pharmaceutically acceptable cocrystals of N-[2-(7-methoxy-1-naphthyl]acetamide and methods of their preparation |
10/31/2012 | EP2517698A2 Agent for treating parkinson's disease |
10/31/2012 | EP2516446A2 Substituted hexahydrochromeno[3,4-b]pyrroles with affinity for the serotonin receptor (5-ht) family |
10/31/2012 | EP2516445A2 Tricyclic derivatives and their pharmaceutical use and compositions |
10/31/2012 | EP2516441A1 Pteridinones as inhibitors of polo-like kinase |
10/31/2012 | EP2516440A1 Bridgehead amine ring -fused indoles and indolines useful to treat neurodegenerative and neuropsychiatry disorders |
10/31/2012 | EP2516439A1 Diaza-spiro[5.5]undecanes as orexin receptor antagonists |
10/31/2012 | EP2516437A1 Disubstituted heteroaryl-fused pyridines |
10/31/2012 | EP2516415A1 Carboxamide compounds and their use as calpain inhibitors iv |
10/31/2012 | EP2516406A1 Mglu2 agonists |
10/31/2012 | EP2516397A1 Amino-heteroaryl derivatives as hcn blockers |
10/31/2012 | EP2516393A1 Carboxamide compounds and their use as calpain inhibitors |
10/31/2012 | EP2516383A1 New aminotetraline derivatives |
10/31/2012 | EP2515924A2 A composition comprising the extract of prunella vulgaris l. for preventing and treating adhd disease and the use thereof |
10/31/2012 | EP2515923A1 Orthosiphon stamineus extracts with beneficial use as cognition enhancer |
10/31/2012 | EP2515922A2 Plant extracts for treating neurodegenerative diseases |
10/31/2012 | EP2515910A1 Use of polysaccharides for treating stress and anxiety |
10/31/2012 | EP2515906A2 Treating critically ill patients with intravenous ibuprofen |
10/31/2012 | EP2515893A2 Compositions comprising venlafaxine and celecoxib in the treatment of pain |
10/31/2012 | EP2515890A1 Neuronal stimulation |
10/31/2012 | EP2515881A2 Process for preparing tablets comprising 5- hydroxytryptophan and tryptophan |
10/31/2012 | EP2515876A2 Pharmaceutical compositions and oral dosage forms of a levodopa prodrug and methods of use |
10/31/2012 | EP2515873A1 Formulation comprising 1 h - quinazoline - 2, 4 - dione ampa receptor antagonists, in the form of immediate release tablets and preparation thereof |
10/31/2012 | EP2515656A1 Aminobenzoquinazolinone m1 receptor positive allosteric modulators |
10/31/2012 | EP2515655A1 1h-pyrazolo[3,4-beta]pyridines and therapeutic uses thereof |
10/31/2012 | EP2515654A1 Novel ergoline analogs |
10/31/2012 | EP2515647A1 Pheromone compositions and methods of use |
10/31/2012 | CN102762575A Multicyclic compounds and methods of use thereof |
10/31/2012 | CN102762573A Compounds, compositions and methods for protecting brain health in neurodegenerative disorders |
10/31/2012 | CN102762572A Pyrazolo[5,1b]oxazole derivatives as crf-1 receptor antagonists |
10/31/2012 | CN102762568A Pteridinones as inhibitors of polo - like kinase |
10/31/2012 | CN102762567A Diaza-spiro[5.5]undecanes as orexin receptor antagonists |
10/31/2012 | CN102762561A Gamma secretase modulaters |
10/31/2012 | CN102762560A Disubstituted heteroaryl-fused pyridines |
10/31/2012 | CN102762559A Diphenyl-pyrazolopyrdine derivatives, preparation thereof, and use thereof as nuclear receptor not modulators |
10/31/2012 | CN102762554A (r)-4-((4-((4-(tetrahydrofuran-3-yloxy)benzo[d]isoxazol-3-yloxy)methyl)piperidin-1-yl)methyl)tetrahydro-2h-pyran-4-ol, a partial agonist of 5-ht4 receptors |
10/31/2012 | CN102762228A Human anti-ngf neutralizing antibodies as selective ngf pathway inhibitors |
10/31/2012 | CN102762207A NMDA receptor antagonists for the treatment of neuropsychiatric disorders |
10/31/2012 | CN102762201A Methods for treating attention-deficit/hyperactivity disorder |
10/31/2012 | CN102757937A Phenol-red-containing serum-free culture system for culturing neurons and new application of phenol red |
10/31/2012 | CN102757880A Maca health-care wine and preparation method thereof |
10/31/2012 | CN102757471A Novel active cytidine disodium triphosphate compound and pharmaceutical composition thereof |
10/31/2012 | CN102757448A Macrocyclic kinase inhibitor compound, preparation method and application thereof as drug |
10/31/2012 | CN102757441A Furano[3,2-g]chromene compounds and applications thereof |
10/31/2012 | CN102755646A Medicament for treating TNF alpha related disorder |
10/31/2012 | CN102755636A Application of bFGF (basic Fibroblast Growth Factor) to preparation of medicament for treating human ischemic stroke |
10/31/2012 | CN102755633A Application of human recombinant protein PDCD5 to treatment of autoimmune disease |
10/31/2012 | CN102755631A Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
10/31/2012 | CN102755592A Traditional Chinese medicine preparation for treating schizophrenia |
10/31/2012 | CN102755555A Traditional Chinese medicine for treating infant night cry |
10/31/2012 | CN102755543A Consciousness-restoring and epilepsy-relieving pill |
10/31/2012 | CN102755535A Oral liquid for improving high sleep quality |
10/31/2012 | CN102755529A Decoction medicine for treating insomnia caused by deficiency of heart-qi and gallbladder-qi |
10/31/2012 | CN102755526A Chinese medicine composition for treating insomnia |
10/31/2012 | CN102755511A Traditional Chinese medicine health-care powder for treating insomnia |
10/31/2012 | CN102755510A Drug composition for treating depression |
10/31/2012 | CN102755490A Flavored nine-Xiang powder for treating Parkinson's disease |
10/31/2012 | CN102755483A Traditional Chinese medicinal plaster for treating sciatica caused by blood stasis |
10/31/2012 | CN102755479A Smoking-quitting Chinese medicine |
10/31/2012 | CN102755470A Cataplasm for treating cancer pain and preparation method thereof |
10/31/2012 | CN102755465A Traditional Chinese medicine decoction for treating insomnia caused by liver depression transforming into fire |
10/31/2012 | CN102755429A Chinese medicinal liquor for quitting smoking |
10/31/2012 | CN102755404A Method for decocting Chinese magnoliavine fruit |
10/31/2012 | CN102755391A Preparing method of corydalis tuber |
10/31/2012 | CN102755380A Composition for treating cerebral injury and neurodegenerative symptoms |
10/31/2012 | CN102755374A Acceleration agent of calcium absorption |
10/31/2012 | CN102755346A Compound polysaccharide formula of edible fungus as well as preparation method and application thereof |
10/31/2012 | CN102755343A Application of daucosterol in preparing medicines for promoting proliferation of neural stem cells |
10/31/2012 | CN102755341A Application of acteoside in preparing medicine for treating alzheimer disease |
10/31/2012 | CN102755334A Medicine composition of cycloartenyl ferulate |
10/31/2012 | CN102755312A Application of compound with flavone skeleton structure as Parkinsonism treating medicine |
10/31/2012 | CN102755310A Composition drug preparation containing levodopa |
10/31/2012 | CN102755302A Delayed release preparation containing safe and reliable plasticizer and preparation method thereof |
10/31/2012 | CN102755059A Nerves soothing medicinal pillow |
10/31/2012 | CN102755049A Quilt cover for treating hyperactivity of child |
10/31/2012 | CN102397279B Application of friedelin-3 beta-alcohol to preparation of vascular dementia-resisting medicaments |
10/31/2012 | CN102283975B Oral liquid for curing anhypnia |
10/31/2012 | CN102228659B Chinese medicinal composition for treating generalized anxiety disorder and preparation method thereof |
10/31/2012 | CN102228505B Chinese medicinal composition with effects of nourishing heart and tranquilizing mind and preparation method and detection method thereof |
10/31/2012 | CN102225186B Medicine for treating neurosis and preparation method thereof |
10/31/2012 | CN102205001B Traditional Chinese medicine for treating neuropathic heart disease |
10/31/2012 | CN102204883B Promethazine hydrochloride microenema prescription and preparation method thereof |
10/31/2012 | CN102133212B Asarone medical composition |
10/31/2012 | CN102120012B Compound preparation comprising American ginseng and alpinia oxyphylla |
10/31/2012 | CN102106865B Application of bi-xanthone glycoside compound in oxidative damage resistance and apoptosis inhibition |
10/31/2012 | CN101972395B Calming and decompressing traditional Chinese medicine composition and preparation method thereof |
10/31/2012 | CN101874811B Preparation method of silica modified nano pearl powder |
10/31/2012 | CN101778826B Azepine derivatives as gamma-secretase inhibitors |
10/31/2012 | CN101723896B Tyrosine derivative histone deacetylases inhibitor and application thereof |